NMOSD

Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare autoimmune disease of the central nervous system that mainly damages the optic nerve and spinal cord. The disease is most common in women between the ages of 30 and 40 and affects fewer than five in 100,000 people worldwide.1

Tn most cases, NMOSD progresses in relapses. Often, patients do not fully recover between NMOSD episodes, so that symptoms gradually develop and do not go away. Severe relapses can lead to permanent neurological damage, visual impairment and disability. It is therefore important to diagnose NMOSD as early as possible and to start treatment quickly to prevent further relapses (relapse prophylaxis). In the treatment of NMOSD, a distinction is made between the treatment of acute relapses and relapse prophylaxis, which is intended to prevent further relapses. Since NMOSD is a progressive disease, the symptoms increase with each relapse. Within five years